New lupus shot enters human testing – could it tame the disease?
NCT ID NCT06625671
First seen Dec 29, 2025 · Last updated Apr 29, 2026 · Updated 18 times
Summary
This study tests an experimental injection called DB-2304 in healthy volunteers and people with lupus (SLE or CLE). The main goal is to check safety and side effects, not to cure the disease. About 148 participants will be monitored closely. If safe, the drug may help control lupus symptoms, but ongoing treatment would still be needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site AUS01-0
COMPLETEDMelbourne, Victoria, 3004, Australia
-
US02-0
RECRUITINGSan Antonio, Texas, 78215, United States
-
US03-0
RECRUITINGClearwater, Florida, 33765, United States
-
US04-0
RECRUITINGIrving, Texas, 75061, United States
Conditions
Explore the condition pages connected to this study.